1.. Introduction
================

As part of our ongoing investigation into the isolation of new natural substances from octocorals collected in the tropical West Pacific Ocean, a series of interesting diterpenoids, including cembrane-type \[[@b1-marinedrugs-09-00934]\], eunicellin-type (2,11-cyclized cembranoid) \[[@b2-marinedrugs-09-00934]--[@b4-marinedrugs-09-00934]\], and briarane-type (3,8-cyclized cembranoid) \[[@b5-marinedrugs-09-00934]--[@b7-marinedrugs-09-00934]\] diterpenoids, were isolated from various octocorals belonging to the genera *Briareum*, *Cladiella*, *Ellisella*, and *Junceella*. The chemical constituents of an Indonesian octocoral identified as *Cladiella* sp. were examined, and nine new eunicellin-based diterpenoids, including cladieunicellins A--E \[[@b2-marinedrugs-09-00934]\] and cladielloides A--D \[[@b3-marinedrugs-09-00934],[@b4-marinedrugs-09-00934]\], were isolated. Further study of this coral yielded two new eunicellins, cladieunicellin F (**1**) and (--)-solenopodin C (**2**). In this paper, we report the isolation, structure determination, and bioactivity of new eunicellins **1** and **2** ([Figure 1](#f1-marinedrugs-09-00934){ref-type="fig"}).

2.. Results and Discussion
==========================

Cladieunicellin F (**1**) was isolated as a colorless oil and the molecular formula for this compound was determined using HRESIMS to be C~20~H~34~O~3~ (four degrees of unsaturation) (*m/z* 345.2404 \[M + Na\]^+^, calculated for 345.2406). Comparison of the ^13^C NMR and DEPT data with the molecular formula indicated that there must be two exchangeable protons, which required the presence of two hydroxyl groups. This deduction was supported by a broad absorption in the IR spectrum at 3414 cm^−1^. The ^13^C NMR data for **1** confirmed the presence of twenty carbon signals ([Table 1](#t1-marinedrugs-09-00934){ref-type="table"}), which were characterized by DEPT as four methyls, an sp^2^ methylene, six sp^3^ methylenes, six sp^3^ methines (including two oxymethines), two sp^3^ oxygenated quaternary carbons, and an sp^2^ quaternary carbon. Based on the ^1^H and ^13^C NMR spectra ([Table 1](#t1-marinedrugs-09-00934){ref-type="table"}), **1** was determined to possess an exocyclic carbon-carbon double bond (*δ*~H~ 5.06, 2H, br s, H~2~-16; *δ*~C~ 150.6, s, C-7; 111.8, t, C-16). The presence of a trisubstituted epoxide containing a methyl substituent was established from the signals of an oxygenated quaternary carbon (*δ*~C~ 62.9, s, C-3) and an oxymethine (*δ*~H~ 2.81, 1H, d, *J* = 9.6 Hz; *δ*~C~ 64.8, d, CH-2) and confirmed by the proton signal of a methyl singlet at *δ*~H~ 1.36 (3H, s, H~3~-15). In the ^1^H NMR spectrum of **1**, two doublets at *δ*~H~ 0.88 and 0.81 (each 3H, d, *J* = 6.4 Hz, H~3~-19 and H~3~-20) were indicative of the two methyls of an isopropyl group. A tertiary methyl group bonded to an oxygenated carbon was evident from the singlet signal at *δ*~H~ 1.24 (3H, s, H~3~-17). Thus, from the reported data, the proposed skeleton of **1** was suggested to be an eunicellin-based diterpenoid with three rings.

From the ^1^H--^1^H COSY spectrum of **1** ([Table 1](#t1-marinedrugs-09-00934){ref-type="table"}), it was possible to differentiate among the separate spin systems of H-1/H-2, H~2~-4/H~2~-5/H-6, H~2~-8/H~2~-9/H-10/H-1, H~2~-12/H~2~-13/H-14/H-1, and H-14/H-18/H~3~-19 (H~3~-20), which was accomplished with the assistance of an HMBC experiment ([Table 1](#t1-marinedrugs-09-00934){ref-type="table"}). The key HMBC correlations between the protons and quaternary carbons of **1**, including H-1, H-2, H~2~-4, H~2~-5, H~3~-15/C-3; H~2~-5, H-8b, H-9b, H~2~-16/C-7; and H-1, H-10, H~2~-12, H~2~-13, H~3~-17/C-11, permitted the elucidation of the carbon skeleton. An exocyclic carbon-carbon double bond at C-7 was confirmed by the HMBC correlations between H~2~-16/C-6, -7, -8; H-6/C-16; and H-8b/C-16 and further supported by the allylic coupling between H-8b/H~2~-16. The presence of the C-2/3 epoxide group was confirmed by the HMBC correlations between H-1/C-2, -3; H-2/C-1, -3, -10, -15; H~2~-4/C-2, -3; and H~3~-15/C-2, -3, -4. Thus, the remaining hydroxyl groups should be positioned at C-6 and C-11, as indicated by the key ^1^H--^1^H COSY correlations and characteristic NMR signals, although the hydroxyl protons for OH-6 and OH-11 were not observed in the ^1^H NMR spectrum of **1**.

The relative configuration of **1** was elucidated from the interactions observed in a NOESY experiment ([Figure 2](#f2-marinedrugs-09-00934){ref-type="fig"}): H-1 correlated with H-10 and H~3~-20, indicating that H-1, H-10, and the isopropyl group are situated on the same face and assigned as β protons. H-2 exhibited interactions with H-14 and Me-17, and no correlation was found between H-1/H-2, H-10/Me-17, and H-2/Me-15, indicating that H-2, H-14, and Me-17 should be α-oriented and Me-15 should be β-oriented. Furthermore, H-6 correlated with two protons of the C-9 methylene and Me-15. Consideration of molecular models found that H-6 was reasonably close to H~2~-9 and Me-15 when H-6 was β-oriented in **1**. Based on the above findings, the structure of **1**, including its relative configuration, was established, and the chiral centers for **1** were assigned as 1*R*\*, 2*S*\*, 3*S*\*, 6*R*\*, 10*R*\*, 11*R*\*, and 14*R*\*. To the best of our knowledge, cladieunicellin F (**1**) is the first eunicellin derivative possessing a C-2/3 epoxy group.

Eunicellin **2** was isolated as a colorless oil, and the molecular formula of this compound was determined using HRESIMS to be C~20~H~34~O~2~ (*m/z* 329.2455 \[M + Na\]^+^, calculated for 329.2456). Thus, four degrees of unsaturation were determined for **2**. Detailed analysis of the NMR data showed that the data for **2** were similar to those of a known eunicellin analogue, solenopodin C (**3**) ([Figure 1](#f1-marinedrugs-09-00934){ref-type="fig"}), which was isolated from the gorgonian *Solenopodium stechei* \[[@b8-marinedrugs-09-00934]\]. However, the optical rotation value of **2** ( ${\lbrack\alpha\rbrack}_{\text{D}}^{22}$ −51 (*c* 0.17, CHCl~3~)) was substantially different from that of **3** ( ${\lbrack\alpha\rbrack}_{\text{D}}^{22}$ +105.6 (*c* 0.36)), indicating that eunicellin **2** is an enantiomer of **3** and should be designated (--)-solenopodin C. The ^1^H and ^13^C NMR data for **2** ([Table 2](#t2-marinedrugs-09-00934){ref-type="table"}) were assigned using 2D NMR data analysis and comparison to the NMR data of **3**. The proton chemical shifts for C-8, C-9, C-12, and C-13 methylene protons and the carbon chemical shifts for C-1, C-4, C-12, and C-14 of compound **3** should be revised ([Table 2](#t2-marinedrugs-09-00934){ref-type="table"}).

In a previous study, we reported the isolation and structure determination of two eunicellins, cladielloides A (**4**) and B (**5**) ([Figure 3](#f3-marinedrugs-09-00934){ref-type="fig"}) \[[@b3-marinedrugs-09-00934]\]. However, based on detailed spectral data analysis, we found that the structures for these two compounds should be revised. 1D and 2D NMR spectral data analysis, particularly ^1^H--^1^H COSY and HMBC experiments, of cladielloide A ([Table 3](#t3-marinedrugs-09-00934){ref-type="table"}), showed that the main carbon skeleton of cladielloide A was established correctly. However, in the HMBC experiment for cladielloide A, key correlations between H-4 (*δ*~H~ 5.14) and an ester carbonyl at *δ*~C~ 171.4 (s, C-1′) and between H-2′ (*δ*~H~ 4.86) and two ester carbonyls at *δ*~C~ 171.4 (s, C-1′) and 171.1 (s, acetate carbonyl) were detected, and these findings indicated that the 2′-acetoxybutyrate group should be positioned at C-4. Thus, the remaining hydroxyl groups are attached at C-3 and C-6 in cladielloide A, respectively. Furthermore, in the NOESY spectrum of cladielloide A, H-6 (*δ*~H~ 4.21) correlated with H~2~-5 (*δ*~H~ 2.97 and 1.75) and H~2~-8 (*δ*~H~ 2.35), but no correlation was found between H-6 and H~3~-15. Consideration of molecular models found that H-6 was reasonably close to H~2~-5 and H~2~-8 when it was β-oriented. Based on the above findings, the structure, including the relative configuration, of cladielloide A should be revised as presented in eunicellin **6**. Cladielloide B was found by HRESIMS to be an isomer of cladielloide A \[[@b3-marinedrugs-09-00934]\]. These two compounds were found to possess the same planar structure by NMR data analysis ([Tables 3](#t3-marinedrugs-09-00934){ref-type="table"} and [4](#t4-marinedrugs-09-00934){ref-type="table"}). In the NOESY experiment of cladielloide B, H-6 (*δ*~H~ 4.66) exhibited correlations with H~3~-15 (*δ*~H~ 1.33); a proton of C-5 methylene (*δ*~H~ 2.48); and a proton of C-8 methylene (*δ*~H~ 2.65), indicating that the 6-hydroxyl group in cladielloide B should be β-oriented as presented as eunicellin **7**. Based on the above findings, the structures of cladielloides A and B should be revised as structures **6** and **7**, respectively. The authors apologize for any inconvenience caused by these errors.

The *in vitro* anti-inflammatory effects of eunicellins **1** and **2** were tested. Eunicellin **2** displayed significant inhibitory effects on the generation of superoxide anion and the release of elastase by human neutrophils at a concentration of 10 μg/mL ([Table 5](#t5-marinedrugs-09-00934){ref-type="table"}).

3.. Experimental Section
========================

3.1.. General Experimental Procedures
-------------------------------------

Optical rotation values were measured with a JASCO P-1010 digital polarimeter. Infrared spectra were obtained on a VARIAN DIGLAB FTS 1000 FT-IR spectrophotometer. The NMR spectra were recorded on a VARIAN MERCURY PLUS 400 FT-NMR at 400 MHz and 100 MHz for ^1^H and ^13^C spectra, respectively, in CDCl~3~ at 25 °C. Proton chemical shifts were referenced to the residual CHCl~3~ signal (*δ*~H~ 7.26 ppm). ^13^C NMR spectra were referenced to the center peak of CDCl~3~ at *δ*~C~ 77.1 ppm. ESIMS and HRESIMS data were recorded on a BRUKER APEX II mass spectrometer. Column chromatography was performed on silica gel (230--400 mesh, Merck, Darmstadt, Germany). TLC was carried out on precoated Kieselgel 60 F~254~ (0.25 mm, Merck), and spots were visualized by spraying with 10% H~2~SO~4~ solution followed by heating. HPLC was performed using a system comprised of a HITACHI L-2130 pump, a HITACHI photodiode array detector L-2455, and a RHEODYNE 7725 injection port. A reverse phase column (Polaris 5 C18-A 250 × 10.0 mm, Varian, silica gel 60, 5 μm) was used for HPLC.

3.2.. Animal Material
---------------------

The octocoral *Cladiella* sp. was collected and imported legitimately by the National Museum of Marine Biology and Aquarium (NMMBA), Taiwan from Indonesia in 2004. The material was stored in a freezer until extraction procedures were applied. A voucher specimen (NMMBA-IND-SC-001) was deposited in the NMMBA, Taiwan. This organism was identified by comparison with previous descriptions \[[@b10-marinedrugs-09-00934],[@b11-marinedrugs-09-00934]\].

3.3.. Extraction and Isolation
------------------------------

Sliced bodies of *Cladiella* sp. (wet weight, 924 g) were extracted with a mixture of MeOH and CH~2~Cl~2~ (1:1), and the residue collected after solvent evaporation was partitioned between EtOAc and H~2~O. The EtOAc layer was subjected to silica gel column chromatography and eluted using a mixture of *n*-hexane and EtOAc (stepwise from 100:1 to 0:100 *n*-hexane:EtOAc) to obtain 19 fractions, labeled A--S. Fractions F and I were separated by reverse phase HPLC using a mixture of MeOH and water to afford eunicellins **2** (3.3 mg, 1/1) and **1** (1.5 mg, 1/1), respectively.

Cladieunicellin F (**1**): colorless oil; ${\lbrack\alpha\rbrack}_{\text{D}}^{23}$ −194 (*c* 0.07, CHCl~3~); IR (neat) ν~max~ 3414 cm^−1;\ 1^H NMR (CDCl~3~, 400 MHz) and ^13^C NMR (CDCl~3~, 100 MHz) data, see [Table 1](#t1-marinedrugs-09-00934){ref-type="table"}; ESIMS *m/z* 345 \[M + Na\]^+^; HRESIMS *m/z* 345.2404 (Calcd for 345.2406).

(--)-Solenopodin C (**2**): colorless oil; ${\lbrack\alpha\rbrack}_{\text{D}}^{22}$ −51 (*c* 0.17, CHCl~3~); IR (neat) ν~max~ 3427 cm^−1;\ 1^H NMR (CDCl~3~, 400 MHz) and ^13^C NMR (CDCl~3~, 100 MHz) data, see [Table 2](#t2-marinedrugs-09-00934){ref-type="table"}; ESIMS *m/z* 329 \[M + Na\]^+^; HRESIMS *m/z* 329.2455 (Calcd for 329.2456).

3.4.. Superoxide Anion Generation and Elastase Release by Human Neutrophils
---------------------------------------------------------------------------

Human neutrophils were obtained using dextran sedimentation and Ficoll centrifugation. Measurements of superoxide anion generation and elastase release were carried out according to previously described procedures \[[@b12-marinedrugs-09-00934],[@b13-marinedrugs-09-00934]\]. Briefly, superoxide anion production was assayed by monitoring the superoxide dismutase-inhibitable reduction of ferricytochrome *c*. Elastase release experiments were performed using MeO-Suc-Ala-Ala-Pro-Valp-nitroanilide as the elastase substrate.
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###### 

^1^H and ^13^C NMR data, ^1^H--^1^H COSY, and HMBC correlations for diterpenoid **1**.

  **C/H**   **^1^H[^a^](#tfn1-marinedrugs-09-00934){ref-type="table-fn"}**       **^13^C[^b^](#tfn2-marinedrugs-09-00934){ref-type="table-fn"}**   **^1^H--^1^H COSY**      **HMBC (H→C)**
  --------- -------------------------------------------------------------------- ----------------------------------------------------------------- ------------------------ ------------------------------------------------------------
  1         2.12 m                                                               36.0 (d)[^d^](#tfn4-marinedrugs-09-00934){ref-type="table-fn"}    H-2, H-10, H-14          C-2, C-3, C-9, C-10, C-11, C-14, C-18
  2         2.81 d (9.6)[^c^](#tfn3-marinedrugs-09-00934){ref-type="table-fn"}   64.8 (d)                                                          H-1                      C-1, C-3, C-10, C-15
  3                                                                              62.9 (s)                                                                                   
  4a        1.27 m                                                               27.3 (t)                                                          H-4b, H~2~-5             C-3, C-5, C-15
   b        1.81 m                                                                                                                                 H-4a, H~2~-5             C-2, C-3, C-5, C-6, C-15
  5         2.01 m                                                               30.3 (t)                                                          H~2~-4, H-6              C-3, C-4, C-6, C-7
  6         4.20 dd (10.4, 4.0)                                                  68.4 (d)                                                          H~2~-5                   C-16
  7                                                                              150.6 (s)                                                                                  
  8a        2.16 m                                                               37.5 (t)                                                          H-8b, H~2~-9             n.o.[^e^](#tfn5-marinedrugs-09-00934){ref-type="table-fn"}
   b        2.61 m                                                                                                                                 H-8a, H~2~-9, H~2~-16    C-7, C-9, C-10, C-16
  9a        1.44 m                                                               22.9 (t)                                                          H~2~-8, H-9b, H-10       n.o.
   b        1.96 m                                                                                                                                 H~2~-8, H-9a, H-10       C-1, C-7, C-8
  10        1.68 dd (10.8, 6.0)                                                  46.1 (d)                                                          H-1, H~2~-9              C-1, C-2, C-8, C-9, C-11, C-12, C-17
  11                                                                             72.9 (s)                                                                                   
  12        1.59 m                                                               37.2 (t)                                                          H~2~-13                  C-10, C-11, C-13, C-14, C-17
  13a       1.55 m                                                               21.8 (t)                                                          H~2~-12, H-13b, H-14     C-11, C-12, C-14
   b        1.71 m                                                                                                                                 H~2~-12, H-13a, H-14     C-11, C-12, C-14
  14        1.32 m                                                               41.5 (d)                                                          H-1, H~2~-13, H-18       C-13
  15        1.36 s                                                               21.8 (q)                                                                                   C-2, C-3, C-4
  16        5.06 br s                                                            111.8 (t)                                                         H-8b                     C-6, C-7, C-8
  17        1.24 s                                                               24.4 (q)                                                                                   C-10, C-11, C-12
  18        1.81 m                                                               26.5 (d)                                                          H-14, H~3~-19, H~3~-20   C-14, C-19, C-20
  19        0.88 d (6.4)                                                         20.6 (q)                                                          H-18                     C-14, C-18, C-20
  20        0.81 d (6.4)                                                         21.7 (q)                                                          H-18                     C-14, C-18, C-19

Spectra were measured at 400 MHz in CDCl~3~.

Spectra were measured at 100 MHz in CDCl~3~.

*J* values (in hertz) are in parentheses.

Attached protons were deduced by DEPT and HMQC experiments.

n.o. = not observed.

###### 

^1^H and ^13^C NMR data for diterpenoids **2** and **3**.

  **C/H**   **2**                                                                            **3**                                                                                       
  --------- -------------------------------------------------------------------------------- ---------------------------------------------------------------- -------------------------- -----------
  1         2.73 ddd (7.6, 6.0, 6.0)[^c^](#tfn8-marinedrugs-09-00934){ref-type="table-fn"}   36.6 (d)[^d^](#tfn9-marinedrugs-09-00934){ref-type="table-fn"}   2.73 ddd (7.5, 6, 6)       44.8 (d)
  2         5.35 d (7.6)                                                                     130.4 (d)                                                        5.34 br d (7.5)            130.4 (d)
  3                                                                                          134.3 (s)                                                                                   134.3 (s)
  4a        2.47 ddd (13.2, 13.2, 2.8)                                                       28.0 (t)                                                         2.47 ddd (13.4, 13, 2.2)   35.2 (t)
   b        1.95 m                                                                                                                                            1.9 m                      
  5a        2.13 m                                                                           25.3 (t)                                                         2.1 m                      25.3 (t)
   b        1.37 m                                                                                                                                            1.3 m                      
  6         3.10 dd (10.8, 3.6)                                                              65.9 (d)                                                         3.10 dd (11.2, 3.5)        65.9 (d)
  7                                                                                          61.2 (s)                                                                                    61.1 (s)
  8a        2.14 m                                                                           38.6 (t)                                                         2.3 m                      38.6 (t)
   b        0.93 m                                                                                                                                                                       
  9a        1.58 m                                                                           22.5 (t)                                                         1.2--1.7 m                 22.2 (t)
   b        0.90 m                                                                                                                                                                       
  10        1.95 m                                                                           47.3 (d)                                                         1.95 ddd (6, 6, 6)         47.3 (d)
  11                                                                                         73.2 (s)                                                                                    73.2 (s)
  12a       1.52 m                                                                           35.2 (t)                                                                                    28.1 (t)
    b       1.49 m                                                                                                                                                                       
  13a       1.56 m                                                                           20.0 (t)                                                                                    20.0 (t)
    b       1.45 m                                                                                                                                                                       
  14        1.02 m                                                                           44.7 (d)                                                         1.0 m                      36.6 (d)
  15        1.71 s                                                                           24.9 (q)                                                         1.71 s                     24.9 (q)
  16        1.18 s                                                                           18.2 (q)                                                         1.22 s                     18.2 (q)
  17        1.22 s                                                                           26.7 (q)                                                         1.18 s                     26.8 (q)
  18        1.95 m                                                                           26.6 (d)                                                         1.90 m                     26.6 (d)
  19        0.97 d (6.8)                                                                     22.0 (q)                                                         0.78 d (7)                 22.0 (q)
  20        0.78 d (6.8)                                                                     17.6 (q)                                                         0.98 d (7)                 17.7 (q)

Spectra were measured at 400 MHz in CDCl~3~.

Spectra were measured at 100 MHz in CDCl~3~.

*J* values (in hertz) are in parentheses.

Attached protons were deduced by DEPT and HMQC experiments.

Data were reported by Bloor et al. \[[@b8-marinedrugs-09-00934]\]. These data were measured at 300 MHz for ^1^H and 75 MHz for ^13^C in CDCl~3~.

###### 

^1^H and ^13^C NMR data, ^1^H--^1^H COSY, and HMBC correlations for cladielloide A (**6**).

  **C/H**   **^1^H[^a^](#tfn11-marinedrugs-09-00934){ref-type="table-fn"}**                   **^13^C[^b^](#tfn12-marinedrugs-09-00934){ref-type="table-fn"}**   **^1^H--^1^H COSY**      **HMBC (H→C)**
  --------- --------------------------------------------------------------------------------- ------------------------------------------------------------------ ------------------------ -------------------------------------------------------------
  1         2.74 ddd (8.0, 8.0, 4.0)[^c^](#tfn13-marinedrugs-09-00934){ref-type="table-fn"}   39.7 (d)[^d^](#tfn14-marinedrugs-09-00934){ref-type="table-fn"}    H-2, H-10, H-14          C-2, C-3, C-10, C-11, C-14
  2         3.86 d (8.0)                                                                      87.1 (d)                                                           H-1                      C-3, C-4, C-14, C-15
  3                                                                                           74.1 (s)                                                                                    
  4         5.14 dd (4.4, 4.4)                                                                74.6 (d)                                                           H~2~-5                   C-3, C-6, C-15, C-1′
  5α        2.97 ddd (16.0, 4.4, 2.8)                                                         37.2 (t)                                                           H-4, H-5β, H-6           C-3
   β        1.75 ddd (16.0, 5.6, 3.6)                                                                                                                            H-4, H-5α, H-6           C-3, C-4, C-7
  6         4.21 br s                                                                         72.6 (d)                                                           H~2~-5, OH-6             n.o.[^e^](#tfn15-marinedrugs-09-00934){ref-type="table-fn"}
  7                                                                                           147.6 (s)                                                                                   
  8         2.35 br d (2.4)                                                                   40.0 (t)                                                           H-9                      C-6, C-7, C-9, C-10, C-16
  9         4.16 ddd (3.6, 3.2, 3.2)                                                          81.3 (d)                                                           H~2~-8, H-10             n.o.
  10        2.63 br s                                                                         44.6 (d)                                                           H-1, H-9                 C-11
  11                                                                                          132.1 (s)                                                                                   
  12        5.43 m                                                                            122.2 (d)                                                          H~2~-13, H~3~-17         n.o.
  13α       2.10 m                                                                            22.8 (t)                                                           H-12, H-13β, H-14        n.o.
    β       1.98 m                                                                                                                                               H-12, H-13α, H-14        n.o.
  14        1.58 m                                                                            39.0 (d)                                                           H-1, H~2~-13, H-18       n.o.
  15        1.37 s                                                                            22.4 (q)                                                                                    C-2, C-3, C-4
  16a       5.21 s                                                                            115.2 (t)                                                          H-16b                    C-6, C-8
    b       5.58 s                                                                                                                                               H-16a                    C-6, C-7, C-8
  17        1.68 d (0.8)                                                                      22.0 (q)                                                           H-12                     
  18        1.15 m                                                                            28.8 (d)                                                           H-14, H~3~-19, H~3~-20   
  19        0.92 d (6.4)                                                                      21.3 (q)                                                           H-18                     C-14, C-18, C-20
  20        0.83 d (6.4)                                                                      20.5 (q)                                                           H-18                     C-14, C-18, C-19
  OH-6      2.84 d (7.2)                                                                                                                                         H-6                      n.o.
  1′                                                                                          171.4 (s)                                                                                   
  2′        4.86 dd (6.8, 6.0)                                                                74.4 (d)                                                           H~2~-3′                  C-1′, C-3′, C-4′, acetate carbonyl
  3′        1.91 m                                                                            24.3 (t)                                                           H-2′, H~3~-4′            C-1′, C-2′, C-4′
  4′        1.03 t (7.2)                                                                      9.3 (q)                                                            H~2~-3′                  C-2′, C-3′
  2′-OAc                                                                                      171.1 (s)                                                                                   
            2.14 s                                                                            20.6 (q)                                                                                    Acetate carbonyl

Spectra were measured at 400 MHz in CDCl~3~.

Spectra were measured at 100 MHz in CDCl~3~.

*J* values (in hertz) are in parentheses.

Attached protons were deduced by DEPT and HMQC experiments.

n.o. = not observed.

###### 

^1^H and ^13^C NMR data, ^1^H--^1^H COSY, and HMBC correlations for cladielloide B (**7**).

  **C/H**   **^1^H[^a^](#tfn16-marinedrugs-09-00934){ref-type="table-fn"}**       **^13^C[^b^](#tfn17-marinedrugs-09-00934){ref-type="table-fn"}**   **^1^H--^1^H COSY**      **HMBC (H**→**C)**
  --------- --------------------------------------------------------------------- ------------------------------------------------------------------ ------------------------ -------------------------------------------------------------
  1         2.51 m                                                                40.6 (d)[^d^](#tfn19-marinedrugs-09-00934){ref-type="table-fn"}    H-2, H-10, H-14          C-10
  2         3.90 d (3.6)[^c^](#tfn18-marinedrugs-09-00934){ref-type="table-fn"}   88.1 (d)                                                           H-1                      C-1, C-3, C-4, C-10
  3                                                                               74.8 (s)                                                                                    
  4         5.21 dd (8.0, 4.0)                                                    73.8 (d)                                                           H~2~-5                   C-5, C-6, C-1′
  5α        2.48 m                                                                34.2 (t)                                                           H-4, H-5β, H-6           C-6, C-7
   β        1.97 m                                                                                                                                   H-4, H-5α, H-6           n.o.[^e^](#tfn20-marinedrugs-09-00934){ref-type="table-fn"}
  6         4.66 dd (8.8, 3.2)                                                    83.8 (d)                                                           H~2~-5                   C-4, C-7, C-16
  7                                                                               144.2 (s)                                                                                   
  8α        2.65 dd (14.0, 4.8)                                                   41.4 (t)                                                           H-8β, H-9, H-16a         C-7, C-9, C-10, C-16
   β        2.46 dd (14.0, 2.0)                                                                                                                      H-8α, H-9                C-6, C-7, C-16
  9         4.06 br s                                                             82.4 (d)                                                           H~2~-8, H-10             n.o.
  10        2.58 br s                                                             44.7 (d)                                                           H-1, H-9                 C-8, C-9, C-11
  11                                                                              131.1 (s)                                                                                   
  12        5.49 m                                                                123.1 (d)                                                          H~2~-13, H~3~-17         n.o.
  13α       2.01 m                                                                22.9 (t)                                                           H-12, H-13β, H-14        n.o.
    β       1.80 m                                                                                                                                   H-12, H-13α, H-14        n.o.
  14        1.39 m                                                                39.8 (d)                                                           H-1, H~2~-13, H-18       C-1, C-2
  15        1.33 s                                                                22.8 (q)                                                                                    C-2, C-3, C-4
  16a       5.26 s                                                                117.7 (t)                                                          H-8α, H-16b              C-6, C-8
    b       5.47 s                                                                                                                                   H-16a                    C-6, C-7, C-8
  17        1.69 d (1.2)                                                          22.8 (q)                                                           H-12                     C-10, C-11, C-12
  18        1.80 m                                                                27.8 (d)                                                           H-14, H~3~-19, H~3~-20   C-14, C-19, C-20
  19        0.94 d (6.8)                                                          21.7 (q)                                                           H-18                     C-14, C-18, C-20
  20        0.77 d (6.8)                                                          17.5 (q)                                                           H-18                     C-14, C-18, C-19
  1′                                                                              170.2 (s)                                                                                   
  2′        4.87 dd (6.8, 6.0)                                                    74.3 (d)                                                           H~2~-3′                  C-1′, C-3′, C-4′, acetate carbonyl
  3′        1.91 m                                                                24.5 (t)                                                           H-2′, H~3~-4′            C-1′, C-2′, C-4′
  4′        1.02 t (7.2)                                                          9.3 (q)                                                            H~2~-3′                  C-2′, C-3′
  2′-OAc                                                                          171.6 (s)                                                                                   
            2.14 s                                                                20.6 (q)                                                                                    Acetate carbonyl

Spectra were measured at 400 MHz in CDCl~3~.

Spectra were measured at 100 MHz in CDCl~3~.

*J* values (in hertz) are in parentheses.

Attached protons were deduced by DEPT and HMQC experiments.

n.o. = not observed.

###### 

Inhibitory effects of eunicellins **1** and **2** on the generation of superoxide anion and the release of elastase by human neutrophils in response to FMLP/CB.

          **Superoxide anion**                                                      **Elastase release**
  ------- ------------------------------------------------------------------------- -----------------------------------------------------------------------
  **1**   6.46 ± 1.28 [\*\*](#tfn23-marinedrugs-09-00934){ref-type="table-fn"}      12.91 ± 3.56 [\*](#tfn22-marinedrugs-09-00934){ref-type="table-fn"}
  **2**   45.82 ± 2.49 [\*\*\*](#tfn24-marinedrugs-09-00934){ref-type="table-fn"}   40.45 ± 5.80 [\*\*](#tfn23-marinedrugs-09-00934){ref-type="table-fn"}

Percentage of inhibition (Inh%) at 10 μg/mL concentration of **1** and **2**. Results are presented as the mean + S.E.M. (*n* = 3).

*P* \< 0.05,

*P* \< 0.01,

*P* \< 0.001, as compared with the control value \[[@b9-marinedrugs-09-00934]\].
